Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, discusses new therapies for Alzheimer’s Disease. The FDA has currently approved 5 symptomatic therapies for Alzheimer’s disease but there are no drugs that inhibit disease progression. The main barrier to finding new therapies is the lack of people willing to participate in clinical trials.

Reading:
Sabbagh MN. Drug development for Alzheimer’s disease: where are we now and where are we headed? Am J Geriatr Pharmacother. 2009 Jun;7(3):167-85. Review.
Guétin S, Portet F, Picot MC, Pommié C, Messaoudi M, Djabelkir L, Olsen AL, Cano MM, Lecourt E, Touchon J. Effect of music therapy on anxiety and depression in patients with Alzheimer’s type dementia: randomised, controlled study. Dement Geriatr Cogn Disord. 2009;28(1):36-46. Epub 2009 Jul 23.
Davies P, Koppel J. Mechanism-based treatments for Alzheimer’s disease. Dialogues Clin Neurosci. 2009;11(2):159-69. Review.